Found: 15
Select item for more details and to access through your institution.
A randomized phase II study to compare oxaliplatin plus 5-fluorouracil and leucovorin (FOLFOX4) versus oxaliplatin plus raltitrexed (TOMOX) as first-line chemotherapy for advanced colorectal cancer.
- Published in:
- Clinical & Translational Oncology, 2012, v. 14, n. 8, p. 606, doi. 10.1007/s12094-012-0843-x
- By:
- Publication type:
- Article
Phase II trial of fortnightly irinotecan (CPT-11) in the treatment of colorectal cancer patients resistant to previous fluoropyrimidine-based chemotherapy.
- Published in:
- Clinical & Translational Oncology, 2005, v. 7, n. 6, p. 244, doi. 10.1007/BF02710170
- By:
- Publication type:
- Article
Rapid mutation detection in complex genes by heteroduplex analysis with capillary array electrophoresis.
- Published in:
- Electrophoresis, 2005, v. 26, n. 13, p. 2539, doi. 10.1002/elps.200410425
- By:
- Publication type:
- Article
GENCODE reference annotation for the human and mouse genomes.
- Published in:
- Nucleic Acids Research, 2019, v. 47, n. D1, p. D766, doi. 10.1093/nar/gky955
- By:
- Publication type:
- Article
Ensembl 2013.
- Published in:
- Nucleic Acids Research, 2013, v. 41, p. D48, doi. 10.1093/nar/gks1236
- By:
- Publication type:
- Article
K‐mer counting and curated libraries drive efficient annotation of repeats in plant genomes.
- Published in:
- Plant Genome, 2021, v. 14, n. 3, p. 1, doi. 10.1002/tpg2.20143
- By:
- Publication type:
- Article
Correlation of Hypertension and Proteinuria with Outcome in Elderly Bevacizumab-Treated Patients with Metastatic Colorectal Cancer.
- Published in:
- PLoS ONE, 2015, v. 10, n. 1, p. 1, doi. 10.1371/journal.pone.0116527
- By:
- Publication type:
- Article
Molecular Divergence upon EGFR -TKI Resistance Could Be Dependent on the Exon Location of the Original EGFR -Sensitizing Mutation.
- Published in:
- Cancers, 2022, v. 14, n. 18, p. N.PAG, doi. 10.3390/cancers14184446
- By:
- Publication type:
- Article
KRAS, BRAF, EGFR and HER2 gene status in a Spanish population of colorectal cancer.
- Published in:
- Molecular Biology Reports, 2011, v. 38, n. 2, p. 1315, doi. 10.1007/s11033-010-0232-x
- By:
- Publication type:
- Article
PIK3CA mutations in KRAS and BRAF wild type colorectal cancer patients. A study of Spanish population.
- Published in:
- Molecular Biology Reports, 2011, v. 38, n. 2, p. 1347, doi. 10.1007/s11033-010-0236-6
- By:
- Publication type:
- Article
A randomized phase II study of raltitrexed and gefitinib versus raltitrexed alone as second line chemotherapy in patients with colorectal cancer. (1839IL/0143)
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
A randomized phase II study of raltitrexed and gefitinib versus raltitrexed alone as second line chemotherapy in patients with colorectal cancer. (1839IL/0143).
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 5, p. 1038, doi. 10.1007/s10637-010-9400-z
- By:
- Publication type:
- Article
ANTIOXIDANTES NATURALES Y QUIMIOTERAPIA ANTITUMORAL.
- Published in:
- Electronic Journal of Biomedicine, 2011, n. 2, p. 42
- By:
- Publication type:
- Article
Oncogenic driver mutations predict outcome in a cohort of head and neck squamous cell carcinoma (HNSCC) patients within a clinical trial.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-72927-2
- By:
- Publication type:
- Article
TAp73 is one of the genes responsible for the lack of response to chemotherapy depending on B-Raf mutational status.
- Published in:
- Journal of Translational Medicine, 2010, v. 8, p. 15, doi. 10.1186/1479-5876-8-15
- By:
- Publication type:
- Article